This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Sascha Kupke: Innovator in Viral Infection Treatment
Introduction
Sascha Kupke is a notable inventor based in Magdeburg, Germany. He has made significant contributions to the field of virology through his innovative research and patenting efforts. His work focuses on developing solutions for viral infections, particularly through the use of nucleic acid molecules.
Latest Patents
Sascha Kupke holds a patent for a "Protective interfering nucleic acid molecule and virus-like particle, viral vector, or virus particle containing the same as well as pharmaceutical composition containing the protective interfering nucleic acid and its use." This invention relates to an isolated nucleic acid molecule, specifically an RNA molecule with particular substitutions. The patent also covers a composition that includes virus-like particles, viral vectors, or virus particles containing the nucleic acid molecule. These innovations are designed for use as medicaments, particularly in treating viral infections. Furthermore, the patent outlines a pharmaceutical composition suitable for use as a prophylactic vaccine against viral infections, including influenza.
Career Highlights
Sascha Kupke is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., where he conducts his research. His work has led to advancements in the understanding and treatment of viral infections, showcasing his commitment to improving public health through scientific innovation.
Collaborations
Sascha has collaborated with notable colleagues, including Timo Frensing and Pawel Zmora. These partnerships have enhanced his research efforts and contributed to the development of effective solutions for viral infections.
Conclusion
Sascha Kupke's contributions to the field of virology through his innovative patents and research collaborations highlight his role as a key inventor in the fight against viral infections. His work continues to pave the way for advancements in medical treatments and vaccines.
